Advertisement
Advertisement

KNSA

KNSA logo

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

55.11
USD
Sponsored
+0.90
+1.66%
Jun 18, 16:00 UTC -4
Closed
exchange

After-Market

55.55

+0.45
+0.81%

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Profile

About

Kiniksa Pharmaceuticals International plc is a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa Pharmaceuticals International plc is based in LONDON.

Info & Links

CEO

Sanj K. Patel

Headquarters

105 Piccadilly, Second Floor
London, X0 W1J 7NJ, UNITED KINGDOM

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.kiniksa.com

Auditor

PricewaterhouseCoopers LLP

Share holders

--

Employees

366

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

4.27B

Enterprise Value

4.08B

Enterprise Value/EBITDA(ttm)

43.04

Price to Earnings Ratio(ttm)

63.96

Price to Sales(ttm)

5.35

Price to Book(mrq)

6.36

Price to Cash(ytd)

59.63

Profitability

Gross Margin(ttm)

88.40%

Operating Margin(ttm)

8.71%

Profit Margin(ttm)

8.70%

Return on Equity(ttm)

11.48%

Return on Invested Capital(ttm)

11.41%

Return on Assets(ttm)

8.63%

Income Statement

Revenue(ttm)

754.05M

Revenue Per Share(ttm)

9.80

Gross Profit(ttm)

673.44M

EBITDA(ttm)3

94.89M

Net Income Available to Common(ttm)

73.06M

Diluted EPS(ttm)

0.74

Share Statistics

Beta (5Y Monthly)

0.06

52-Week Change

97.17%

S&P 500 52-Week Change

25.41%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

76.94M

Dividend Yield

0.00%

Float4

35.60M

% Held by Insiders

53.48%

% Held by Institutions

53.95%

Balance Sheet

Total Cash(mrq)

468.09M

Total Cash Per Share(mrq)

6.08

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.79%

Quick Ratio(mrq)

3.39%

Book Value Per Share(mrq)

7.44

Cash Flow

Operating Cash Flow Per Share(ytd)

1.75

Free Cash Flow(ytd)

136.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement